Will Brexit Create Undue Disruptions to Medical Supply in the UK?
As the UK prepares to exit the European Union, regulatory responsibilities for medication manufacturers are shifting. Companies potentially affected by Brexit need to ensure that their marketing authorisation remains valid in the coming months. A recent survey[1] conducted by the European Medicines Agency (EMA) showed that 58% of marketing authorisation holders with regulatory ties in [...]